Phase 2 clinical trials enrolled 338 participants across dose groups ranging from 1mg to 12mg weekly
Microplastics and skin aging: disruption of barrier function and induction of fibroblast senescence
Take 14 tablets with meals and a glass of water
En los estudios SURMOUNT para obesidad, produjo una prdida de peso promedio del 15-20% del peso corporal inicial, dependiendo de la dosis utilizada
to reduce excess body weight and maintain weight reduction long term in adults and pediatric patients aged 12 years and older with obesity, and in adults with overweight plus at least one weight-related comorbid condition
Personally, I think that risk is actually overblown and is more of a theoretical risk, but we certainly adhere to that, so we dont prescribe it to this very select population, but thats something a physician and a patient will talk about. Are physicians concerned about the drug being used by patients with eating disorders